These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11677872)

  • 21. Serum levels of clozapine and norclozapine in patients treated with selective serotonin reuptake inhibitors.
    Centorrino F; Baldessarini RJ; Frankenburg FR; Kando J; Volpicelli SA; Flood JG
    Am J Psychiatry; 1996 Jun; 153(6):820-2. PubMed ID: 8633698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross-sensitivity between paroxetine and sertraline.
    Warnock CA; Azadian AG
    Ann Pharmacother; 2002 Apr; 36(4):631-3. PubMed ID: 11918512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?
    Sanchez C; Reines EH; Montgomery SA
    Int Clin Psychopharmacol; 2014 Jul; 29(4):185-96. PubMed ID: 24424469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors.
    Maina G; Albert U; Salvi V; Bogetto F
    J Clin Psychiatry; 2004 Oct; 65(10):1365-71. PubMed ID: 15491240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The transfer of selective serotonin reuptake inhibitors to human milk].
    Nordeng H; Bergsholm YK; Bøhler E; Spigset O
    Tidsskr Nor Laegeforen; 2001 Jan; 121(2):199-203. PubMed ID: 11475200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Switching Selective Serotonin Reuptake Inhibitors in Adolescents with Selective Serotonin Reuptake Inhibitor-Resistant Major Depressive Disorder: Balancing Tolerability and Efficacy.
    Strawn JR; Mills JA; Croarkin PE
    J Child Adolesc Psychopharmacol; 2019 May; 29(4):250-255. PubMed ID: 30810350
    [No Abstract]   [Full Text] [Related]  

  • 27. [New antidepressive agents].
    LaBranche S
    Union Med Can; 1995 Nov; 124(3):8-13. PubMed ID: 8560639
    [No Abstract]   [Full Text] [Related]  

  • 28. Neuroleptic malignant syndrome following combination of sertraline and paroxetine: a case report.
    Uguz F; Sonmez EÖ
    Gen Hosp Psychiatry; 2013; 35(3):327.e7-327.e8. PubMed ID: 23312145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].
    Hjalmarsson L; Corcos M; Jeammet P
    Encephale; 2005; 31(3):309-16. PubMed ID: 16142045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone associated with the use of selective serotonin reuptake inhibitors: a review of spontaneous reports.
    Liu BA; Mittmann N; Knowles SR; Shear NH
    CMAJ; 1996 Sep; 155(5):519-27. PubMed ID: 8804257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective serotonin reuptake inhibitor usage patterns as risk factors for hospitalization.
    Sheffield RE; Lo Sasso AT; Young CH; Way K
    Adm Policy Ment Health; 2002 Nov; 30(2):121-39. PubMed ID: 12680617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of selective serotonin reuptake inhibitors on sexual function.
    Altman CA
    J Clin Psychopharmacol; 2001 Apr; 21(2):241-2. PubMed ID: 11270925
    [No Abstract]   [Full Text] [Related]  

  • 33. The potential for clinically significant drug-drug interactions involving the CYP 2D6 system: effects with fluoxetine and paroxetine versus sertraline.
    Preskorn SH; Shah R; Neff M; Golbeck AL; Choi J
    J Psychiatr Pract; 2007 Jan; 13(1):5-12. PubMed ID: 17242587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neonatal complications after intrauterine exposure to SSRI antidepressants.
    Prescrire Int; 2004 Jun; 13(71):103-4. PubMed ID: 15233148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotonin reuptake inhibitor antidepressants and pregnancy: many unanswered questions.
    Prescrire Int; 1999 Oct; 8(43):157-9. PubMed ID: 11503843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of fluoxetine treatment on carbohydrate metabolism in human blood platelets: a 1H-NMR study.
    Tassini M; Vivi A; Gaggelli E; Valensin G; Laghi Pasini F; Puccetti L; Di Perri T
    Arch Biochem Biophys; 2002 Aug; 404(1):163-5. PubMed ID: 12127081
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of selective serotonin reuptake inhibitors during pregnancy and risk of major and cardiovascular malformations: an update.
    Tuccori M; Montagnani S; Testi A; Ruggiero E; Mantarro S; Scollo C; Pergola A; Fornai M; Antonioli L; Colucci R; Corona T; Blandizzi C
    Postgrad Med; 2010 Jul; 122(4):49-65. PubMed ID: 20675971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dysphonia induced by selective serotonin reuptake inhibitors.
    Petitpain N; Gambier N; Gillet P; Muller JC; de Romemont E
    South Med J; 2005 Aug; 98(8):843. PubMed ID: 16144188
    [No Abstract]   [Full Text] [Related]  

  • 39. Sertraline-induced galactorrhea: case report and review of cases reported with other SSRIs.
    Nebhinani N
    Gen Hosp Psychiatry; 2013; 35(5):576.e3-5. PubMed ID: 23260337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antidepressant-induced sexual dysfunction during treatment with fluoxetine, sertraline and trazodone; a randomized controlled trial.
    Khazaie H; Rezaie L; Rezaei Payam N; Najafi F
    Gen Hosp Psychiatry; 2015; 37(1):40-5. PubMed ID: 25467077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.